Research location

Kuwait City

Kuwait

Published trials58

Site observations68

Linked trials published58

Page1 / 2

Research activity in Kuwait City

Kuwait

CureCurrent currently publishes aggregate city-level research activity for this location: 58 trials and 68 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Kuwait City

58 linked trials · page 1 of 2

Tirzepatide Titration to Reduce Side Effects in Individuals With ObesityNCT07574723 · 2026-05-15 · 1 site observation

LEAN Mass Preservation With Resistance Exercise and Protein During Semaglutide/Tirzepatide TherapyNCT06885736 · 2025-08-07 · 1 site observation

Fibrosis Lessens After Metabolic SurgeryNCT06374875 · 2024-07-11 · 1 site observation

Kuwait Adult Diabetes Epidemiological Multidisciplinary (KADEM) ProgramNCT06115876 · 2022-05-23 · 1 site observation

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsNCT00271180 · 1983-01-01 · 1 site observation

Feasibility and Uptake of Low-Dose CT Lung Cancer Screening in KuwaitNCT07766538 · 2026-09-01 · 1 site observation

NOT_YET_RECRUITING

The Effect of Balance-focused Exercise Programme in Enhancing the Solus-muscle Activation During Gait Initiation for People With Parkinson DiseaseNCT07263646 · 2026-01-22 · 1 site observation

NOT_YET_RECRUITING

Can the Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Prevent the Increase in Plasma Ketone Concentration?NCT06922656 · 2025-09-15 · 1 site observation

NOT_YET_RECRUITING

Compare Multiple Daily Injections With Carbohydrate Counting or With Simplified Qualitative Meal-Size Estimation in Type 1 DiabetesNCT07037810 · 2025-02-17 · 1 site observation

ENROLLING_BY_INVITATION

HER2 TREAT Study: Retrospective Study to Estimate the Prevalence of HER2-low in Unresectable and/or Metastatic Breast Cancer Patients Who Progress on Anti-Cancer Therapy Identified as HER2-Negative From Patient Medical Records in The Gulf Cooperation CouncilNCT06125314 · 2024-03-05 · 1 site observation

Protocol for Alpha MSH Infusion Study in Patients With Type 2 DiabetesNCT06293664 · 2024-03-04 · 1 site observation

Prevalence and Economic Burden of Obesity-related Comorbidities in the Gulf Region: A Retrospective, Observational StudyNCT06288399 · 2023-12-21 · 1 site observation

Resistance Exercise and Cognition in People With Type 1 DiabetesNCT05963152 · 2023-07-20 · 1 site observation

Timing of Resistance Exercise in Type 1 DiabetesNCT05884814 · 2023-07-01 · 1 site observation

Predictors of Bariatric Surgery Weight LossNCT06480058 · 2023-06-20 · 1 site observation

A Multicountry, Multicentre, Non-interventional, Retrospective Study to Determine Real-world Treatment Patterns and Associated Outcomes After First Line Osimertinib in Patients With Advanced and Metastatic NSCLC EGFRm in the GCC RegionNCT06039683 · 2022-12-31 · 1 site observation

Krill Oil and Muscle Weakness in Type 2 DiabetesNCT04943523 · 2022-05-01 · 1 site observation

Vitamin K2 and Muscle Weakness in Type 2 DiabetesNCT05375630 · 2022-03-21 · 1 site observation

Real-world Treatment Patterns and Associated Outcomes in Patients With Resectable Early-stage Non-small Cell Lung CancerNCT04808050 · 2021-11-03 · 1 site observation

Non-interventional, Prospective Study to Determine Prevalence of EGFR Mutations in Non-small Cell Lung CancerNCT04742192 · 2021-03-04 · 1 site observation

Description of Characteristics, Such as Age, Previous and Concurrent Treatments, Associated Diseases, of Patients With Asthma Treated With Dupilumab (DUPIXENT)NCT04550962 · 2020-11-02 · 1 site observation

A Study of Oral Upadacitinib Tablets to Assess Treatment Patterns, Achievement of Treatment Targets and Maintenance of Response in Adult Participants With Moderate to Severe Rheumatoid ArthritisNCT04497597 · 2020-10-16 · 2 site observations

FreeStyle Libre Plus Bluetooth Transmitter Adjunct: Can This Improve Glucose Accuracy and Reduce Burden of HypoglycaemiaNCT04147637 · 2020-10-14 · 1 site observation

Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM PatientsNCT04135287 · 2020-03-01 · 1 site observation

Dapagliflozin Plus Pioglitazone in T1DMNCT03878459 · 2019-08-08 · 1 site observation

ACTIVE_NOT_RECRUITING

Effects of Home-based Resistance Exercise on Body Composition, Muscle Strength and Glycemic Control in People With Type 2 Diabetes.NCT04136730 · 2019-08-01 · 1 site observation

Time-Restricted Feeding on Glucose Homeostasis and Quality of LifeNCT04062773 · 2019-07-10 · 1 site observation

A Feasibility Study Comparing Usual Foot Education and Phone App Alerts in Patients With Increased Risk of Diabetic FootNCT03934944 · 2019-02-10 · 1 site observation

A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical PracticeNCT03782207 · 2019-02-07 · 1 site observation

Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple SclerosisNCT03593590 · 2018-11-12 · 1 site observation

This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS)NCT03599245 · 2018-07-12 · 1 site observation

Twelve -Month Study Observing How Insulin-naïve Patients With Type 2 Diabetes Mellitus Manage Diabetes Using Toujeo® After Oral Antidiabetic Drug Failure, the Side Effect of Toujeo®, and The Cost.NCT03703869 · 2018-03-06 · 6 site observations

Mindfulness-based Arabic Guided Self-help for Parents of Children With Type 1 DiabetesNCT03358394 · 2017-10-26 · 1 site observation

Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)NCT03085810 · 2017-03-24 · 1 site observation

Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During RamadanNCT02941367 · 2017-02-23 · 1 site observation

Documentation of Heart Failure in a Gulf RegistryNCT02793180 · 2016-11-07 · 5 site observations

Real World Assessment of Clinical Outcome Changes -Including Month of Ramadan-for Dapagliflozin in Management of Type II Diabetes MellitusNCT02805361 · 2016-08-21 · 1 site observation

A Pilot Study on Effect of SKY on Psychosocial Parameters of Type 2 Diabetic Patients After a 6 DaysNCT02661906 · 2016-08-01 · 1 site observation

Non-interventional Study to Assess Adherence to Treatment for Patients With RMS (MAIN-MS)NCT02921035 · 2016-06-30 · 1 site observation

An Observational Study to Evaluate Tolerability of Canagliflozin and Sulphonylurea in Type 2 Diabetes Patients During RamadanNCT02737657 · 2016-04-01 · 1 site observation

Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)NCT02642159 · 2016-03-15 · 1 site observation

Extension Study of BG00012 in Pediatric Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)NCT02555215 · 2016-02-22 · 1 site observation

Tracking Biologics Along the Silk RoadNCT03006198 · 2016-02-04 · 1 site observation

Effect of BG00012 on Lymphocyte Subsets and Immunoglobulins in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS).NCT02525874 · 2015-08-11 · 1 site observation

DISCOVERing Treatment Reality of Type 2 Diabetes in Real World SettingsNCT02322762 · 2014-12-30 · 1 site observation

Comparison of Laboratory Changes, Food Intake and Metabolic Profile in Patients With Obesity and Type2 Diabetes Mellitus: Before, During and After Taking AphoelineBrakeNCT02791867 · 2014-12-01 · 1 site observation

Magnesium Treatment of Inflammation in Disorders of Glucose HomeostasisNCT01980459 · 2013-10-01 · 1 site observation

Breathing & Mild Physical Exercise Therapy for AsthmaNCT01509443 · 2012-04-01 · 1 site observation

Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 DiabetesNCT01554618 · 2011-12-02 · 1 site observation

Africa and Middle East Cardiovascular Epidemiological StudyNCT01243138 · 2011-07-01 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.